Generative deep learning is accelerating de novo drug design, by allowing the generation of molecules with desired properties on demand. Chemical language models – which generate new molecules in the form of strings using deep learning – have been particularly successful in this endeavour. Thanks to advances in natural language processing methods and interdisciplinary collaborations, chemical language models are expected to become increasingly relevant in drug discovery. This minireview provides an overview of the current state-of-the-art of chemical language models for de novo design, and analyses current limitations, challenges, and advantages. Finally, a perspective on future opportunities is provided.</p
Generative neural networks trained on SMILES can design innovative bioactive molecules de novo. Thes...
Introduction: Artificial intelligence (AI) has inspired computer-aided drug discovery. The widesprea...
Abstract This work introduces a method to tune a sequence-based generative model for molecular de no...
Generative deep learning is accelerating de novo drug design, by allowing the generation of molecule...
Generative deep learning is accelerating de novo drug design, by allowing the generation of molecule...
Machine learning (ML) and Artificial Intelligence (AI) have had a renaissance during the last few ye...
Drug discovery benefits from computational models aiding the identification of new chemical matter w...
Deep generative models have been an upsurge in the deep learning community since they were proposed....
Generative chemical language models (CLMs) can be used for de novo molecular structure generation by...
The inception of advanced bioactive agents has driven the growth for sustained drug delivery and the...
De novo drug design is a computational approach that generates novel molecular structures from atomi...
It is more pressing than ever to reduce the time and costs for the development of lead compounds in ...
Developing new drugs is a complex and formidable challenge, intensified by rapidly evolving global h...
De novo drug design is a computational approach that generates novel molecular structures from atomi...
© 2020 American Chemical Society. All rights reserved. The discovery of functional molecules is an e...
Generative neural networks trained on SMILES can design innovative bioactive molecules de novo. Thes...
Introduction: Artificial intelligence (AI) has inspired computer-aided drug discovery. The widesprea...
Abstract This work introduces a method to tune a sequence-based generative model for molecular de no...
Generative deep learning is accelerating de novo drug design, by allowing the generation of molecule...
Generative deep learning is accelerating de novo drug design, by allowing the generation of molecule...
Machine learning (ML) and Artificial Intelligence (AI) have had a renaissance during the last few ye...
Drug discovery benefits from computational models aiding the identification of new chemical matter w...
Deep generative models have been an upsurge in the deep learning community since they were proposed....
Generative chemical language models (CLMs) can be used for de novo molecular structure generation by...
The inception of advanced bioactive agents has driven the growth for sustained drug delivery and the...
De novo drug design is a computational approach that generates novel molecular structures from atomi...
It is more pressing than ever to reduce the time and costs for the development of lead compounds in ...
Developing new drugs is a complex and formidable challenge, intensified by rapidly evolving global h...
De novo drug design is a computational approach that generates novel molecular structures from atomi...
© 2020 American Chemical Society. All rights reserved. The discovery of functional molecules is an e...
Generative neural networks trained on SMILES can design innovative bioactive molecules de novo. Thes...
Introduction: Artificial intelligence (AI) has inspired computer-aided drug discovery. The widesprea...
Abstract This work introduces a method to tune a sequence-based generative model for molecular de no...